Page last updated: 2024-09-04

tariquidar and 1-deoxynojirimycin

tariquidar has been researched along with 1-deoxynojirimycin in 1 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(1-deoxynojirimycin)
Trials
(1-deoxynojirimycin)
Recent Studies (post-2010) (1-deoxynojirimycin)
210161381,548141558

Protein Interaction Comparison

ProteinTaxonomytariquidar (IC50)1-deoxynojirimycin (IC50)
Maltase-glucoamylase, intestinalHomo sapiens (human)2.366
Lysosomal acid glucosylceramidaseHomo sapiens (human)1
Lysosomal alpha-glucosidaseHomo sapiens (human)1.015
Sucrase-isomaltase, intestinalHomo sapiens (human)2
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)1.3
Sucrase-isomaltase, intestinalRattus norvegicus (Norway rat)0.3479
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)1.3
Protein-lysine 6-oxidaseHomo sapiens (human)1
Glycogen debranching enzymeHomo sapiens (human)10
Glycogen debranching enzymeOryctolagus cuniculus (rabbit)0.19
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)1.3
Alpha-amylase Geobacillus stearothermophilus1.67
Neutral alpha-glucosidase ABHomo sapiens (human)1.3
Lysosomal alpha-glucosidaseRattus norvegicus (Norway rat)0.3125
Putative alpha-glucosidaseOryza sativa Japonica Group (Japanese rice)0.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butters, TD; Callaghan, R; Dwek, RA; Norris-Cervetto, E; Platt, FM1

Other Studies

1 other study(ies) available for tariquidar and 1-deoxynojirimycin

ArticleYear
Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
    The Journal of biological chemistry, 2004, Sep-24, Volume: 279, Issue:39

    Topics: 1-Deoxynojirimycin; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Ceramides; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Glucosamine; Glucosylceramides; Glucosyltransferases; Glycolipids; Humans; Imino Sugars; Lipids; Morpholines; Quinolines; Time Factors; Vinblastine

2004